Respiratory

A recent Phase IIIb multicountry study has demonstrated that a single oral dose of an antiviral flu treatment can significantly reduce the transmission of influenza within households, offering a potential new strategy for healthcare professionals to mitigate spread during flu season.

Targeting inflammation at its root, a new therapy reduces bronchiectasis exacerbations and slows lung function decline, according to results from a Phase III clinical trial.

Severe obstructive sleep apnea (OSA) is independently associated with elevated C-reactive protein (CRP) levels, a key marker of systemic inflammation and cardiovascular risk, according to new research analyzing over 2,400 patients.

Each flu season, influenza quietly inflicts a heavy toll on U.S. adults aged 18 to 64, with hospitalizations and deaths mounting, especially among older adults and those with chronic conditions.

Vaping prevalence among young adults in Great Britain, particularly use of disposable devices, has significantly declined following the government’s announcement of an impending ban on disposables raising questions about how policy shifts might influence U.S. vaping habits.

Children with persistent asthma who received school-based therapy in Columbus, Ohio experienced marked improvements in asthma control and a sharp reduction in healthcare utilization, according to new research.

A fast, low-cost tuberculosis (TB) test that delivers results in under an hour from blood, saliva, or sputum samples could dramatically improve care in both well-equipped hospitals and resource-limited settings.

Infant symptoms such as wheezing, eczema, vomiting, and diarrhea in the first year of life may serve as early indicators of childhood asthma risk, according to a new study that offers promising insights into early identification strategies for the chronic respiratory disease.